IPO Calendar
Lead Manager
- J P Morgan Chase (482)
- Goldman Sachs (458)
- Morgan Stanley (413)
- Bank of America Merrill Lynch (354)
- Citigroup (222)
- Jefferies (211)
- Credit Suisse (180)
- Barclays (150)
- Cowen and Company (145)
- Deutsche Bank (81)
- Piper Jaffray (70)
- Leerink Partners (69)
- Stifel (65)
- UBS Investment Bank (52)
- Evercore (51)
- RBC Capital (50)
- BMO Capital (49)
- Wells Fargo (45)
- William Blair (37)
- Raymond James (36)
More +
IPO - Pricing (6)
Piper Jaffray
| UnderWriters* | |||||||||||
| Date | Company Name | Sector | Price ($) |
Size (M) |
1 | 2 | 3 | Rank | Turnover | Gain | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 19 | CRISPR Therapeu | Health-Care | 14 | 4 | BRCL | CITI | PPRJ | 47.1% | 0.6% | ||
| Sep 29 | Fulgent Genetic | Health-Care | 9 | 4 | CS | PPRJ | 57.4% | 2% | |||
| Sep 21 | Novan Inc. | Health-Care | 11 | 4 | PPRJ | 45.7% | 64.5% | ||||
| Jul 28 | Tactile Systems | Health-Care | 10 | 4 | CNCD | PPRJ | WB | 39.2% | 10.8% | ||
| Jul 21 | Impinj Inc. | Capital-Goods | 14 | 4 | PPRJ | RBC | 98.9% | 28.4% | |||
| Jun 30 | Syros Pharmaceu | Health-Care | 12.5 | 4 | COWN | PPRJ | 22% | 45.2% | |||
*
Lead manager or one of top three managers in an underwriting team.